M0237Medical Services
Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with
Short description: Intrav inf, toci, first dose
- Effective date
- January 24, 2025
- Termination date
- —
Related codes (M-series)
M0001Advancing cancer care mvpM0002Opt care kidney hlth mvpM0003Opt care episod neuro mvpM0004Qual care neurologic cnd mvpM0005Value in primary care mvpM0010Eom meos paymentM0064Visit for drug monitoringM0075Cellular therapyM0076ProlotherapyM0100Intragastric hypothermiaM0201Pne flu hepb cov home adminM0220Tixagev and cilgav inj
Frequently asked questions
What is HCPCS code M0237?
M0237 is a HCPCS Level II code for Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with.
What category is HCPCS code M0237 in?
M0237 falls under the Medical Services category of HCPCS Level II.
When did HCPCS code M0237 become effective?
M0237 has been effective since January 24, 2025, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.